Showing results (41-50 of 326) with videos related to
Sort By:
Pageof 33
Psychiatrische Praxis|April 17, 2025
[The influence of an age-specific treatment setting on the success of inpatient detoxification treatment in older patients with substance-related disorders]Bodo Lieb, Alessa De Vries, Udo Bonnet, et al.Pharmacopsychiatry|August 1, 2024
SARS-CoV-2-Infection in People Addicted to Illegal Drugs - Is There a Protective Effect of Opioid Maintenance Treatment?Simon Kurzhals, Martin Schäfer, Udo Bonnet, et al.Harm Reduction Journal|August 28, 2024
Knowledge of, and attitude towards, the treatment of hepatitis C in people who inject drugsPatrik Roser, Mona Brunstein, Michael Specka, et al.Pharmacopsychiatry|September 16, 2021
Impact of Psychiatric and Related Somatic Medications on the Duration and Severity of COVID-19: A Retrospective Explorative Multi-center Study from the German Metropolitan Ruhr-areaUdo Bonnet, BenediktBernd Claus, Martin Schaefer, et al.Frontiers in Psychiatry|December 31, 2024
Consumption patterns before and during the COVID-19 pandemic among patients admitted to inpatient drug detoxification treatment: Results of two cross-sectional surveys from 2018 and 2021Patrik Roser, Michael Specka, Udo Bonnet, et al.Substance Use & Misuse|October 11, 2017
Effectiveness of Psychoanalytic-Interactional Group Therapy vs. Behavioral Group Therapy in Routine Outpatient Treatment of Alcohol-Dependent PatientsPeter W Nyhuis, Eva Niederhofer, Norbert Scherbaum, et al.CNS Drug Reviews|September 28, 2002
Moclobemide: evolution, pharmacodynamic, and pharmacokinetic propertiesUdo BonnetFortschritte Der Neurologie-Psychiatrie|December 13, 2018
[A short essay on the spirituality of placebo from an (evolutionary) psychiatric perspective]Udo BonnetFortschritte Der Neurologie-Psychiatrie|June 20, 2024
Ten years of maintenance treatment of severe melancholic depression in an adult woman including discontinuation experiencesUdo BonnetJournal of Psychoactive Drugs|August 29, 2015
Long-Term Ketamine Self-Injections in Major Depressive Disorder: Focus on Tolerance in Ketamine's Antidepressant Response and the Development of Ketamine AddictionUdo BonnetPageof 33